In the intricate landscape of glioma pathogenesis, the elucidation of risk scores derived from pivotal hub genes—RPL3, RPL12, PTEN, IFNGR2, KLF10, PLAUR, MSN, and IKBIP—emerged as a critical component in understanding the disease’s progression and patient stratification. The gene discussed is MSN; the disease is central nervous system cancer.